Results 141 to 150 of about 2,823,581 (316)
Abstract The amyloid/tau/neurodegeneration (ATN) biomarker framework has greatly progressed the diagnosis and staging of Alzheimer's disease (AD). However, recent research highlights neuroinflammation as an equally critical factor in AD pathology across humans, rodents, and non‐human primates (NHPs).
Zhihui Jin+3 more
wiley +1 more source
THE ELECTRONIC STRUCTURE OF CARBAMATE DERIVATIVES AS THE INHIBITORS OF CHOLINESTERASE
Takashi Ban, Chikayoshi Nagata
openalex +1 more source
Pneumonia Risk with Cholinesterase Inhibitors [PDF]
Terry Lynn Hughes+2 more
openaire +3 more sources
Abstract The landscape of Alzheimer's disease (AD) and related dementias (ADRD) diagnosis is evolving rapidly, driven by advances in disease understanding, biomarker tools, and disease‐modifying therapies. Modern diagnostic approaches emphasize biological precision, early detection, and dynamic frameworks that adapt to treatment‐induced changes in ...
Takeshi Iwatsubo+43 more
wiley +1 more source
A CHOLINESTERASE INHIBITOR PRODUCED BY ASPERGILLUS TERREUS
Kôichi Ogata+3 more
openalex +2 more sources
Dementia care and mortality in people experiencing homelessness: A matched cohort study
Abstract INTRODUCTION People experiencing homelessness are disproportionately affected by dementia, yet little is known about their dementia care and mortality rates after a diagnosis. METHODS Homeless (n = 559) and housed (n = 2002) individuals newly diagnosed with dementia were matched on age, sex, diagnosis date, and health region within the ...
Salimah Z. Shariff+4 more
wiley +1 more source
A. Atri+8 more
semanticscholar +1 more source
Cholinergic Degeneration and Cognitive Function in Early GBA1‐Related Parkinson's Disease
Objective The phenotype of patients with Parkinson's disease carrying GBA1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 ...
Sofie Slingerland+6 more
wiley +1 more source
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease
Lon S. Schneider
openalex +2 more sources